menu
    • menu

    Company profile for Outpace Bio

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming. Outpace is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Outpace BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Fairview Ave N., Suite 560 Seattle, WA 98109
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.outpacebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Outpace Bio Presents Data on OPB-101 at SITC 2024 Annual Meeting
    Outpace Bio Presents Data on OPB-101 at SITC 2024 Annual Meeting

    05 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/05/2974965/0/en/Outpace-Bio-to-present-new-data-on-programmed-CAR-T-cell-candidate-OPB-101-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Nov 2024
    Share Share
    Outpace Bio Raises $144M Series B For AI-Powered Cell Therapies
    Outpace Bio Raises $144M Series B For AI-Powered Cell Therapies

    01 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/01/2922848/0/en/Outpace-Bio-Announces-144M-Oversubscribed-Series-B-Financing-to-Advance-AI-powered-Cell-Therapies-into-Clinical-Development.html

    GLOBENEWSWIRE
    01 Aug 2024
    Share Share
    Outpace Bio Announces Multiple Presentations at the 2024 AACR Annual Meeting
    Outpace Bio Announces Multiple Presentations at the 2024 AACR Annual Meeting

    04 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/04/2857642/0/en/Outpace-Bio-Announces-Multiple-Presentations-at-the-2024-American-Association-of-Cancer-Research-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share
    Outpace Bio to Present New Data on Tumor-restricted IL-12 Designed
    Outpace Bio to Present New Data on Tumor-restricted IL-12 Designed

    31 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/31/2770266/0/en/Outpace-Bio-to-Present-New-Data-on-Tumor-restricted-IL-12-Designed-Leveraging-OutSmart-Technology-to-Enhance-Solid-Tumor-T-Cell-Therapies-at-SITC-2023.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle
    Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

    26 May 2023

    // Tyler Patchen ENDPTS

    https://endpts.com/outpace-bio-expands-cell-therapy-rd-nets-research-collaborations-in-seattle/

    Tyler Patchen ENDPTS
    26 May 2023
    Share Share
    Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub
    Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub

    22 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/22/2673283/0/en/Outpace-Bio-Expands-Seattle-Presence-with-Cell-Therapy-Research-Hub-Collaborations-with-Leading-Experts-in-Protein-Design-Cancer-Immunotherapy.html

    GLOBENEWSWIRE
    22 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search